Belle Dumé[email protected]Molecular ImagingRetinal imaging goes high resolutionAge-related macular degeneration affects 26% of Europeans over 60, but its early signs are hard to detect. Swiss researchers have developed a technique that makes it possible to observe the retinal cells involved in the disease in vivo.May 24, 2020Molecular ImagingMagnetized molecules monitor breast cancersA new technique that uses hyperpolarized carbon-13 MRI to monitor the metabolism of different types of breast cancer can identify how rapidly a tumor is growing, U.K. researchers report. The approach could help doctors prescribe the best course of treatment and follow how patients respond.March 5, 2020Clinical NewsHuman protein-based nanoprobes for MRIAn international team of researchers is reporting on the first-ever human protein-based tumor-targeting MRI contrast agent. The biohybrid composite, which can also be easily cleared by the body, could be used to detect tumors in their early stages, thanks to its enhanced MRI contrast and shorter proton relaxation time.July 6, 2017Clinical NewsSmall fluorescent dye eases NIR-II imagingResearchers are reporting on the first small-molecule fluorescent dye for "near-infrared-II" (NIR-II) imaging. The dye, which is rapidly excreted by the body, could be used to image tumors in vivo and for image-guided surgery and therapy (Nature Materials, 23 November 2015).December 10, 2015Page 1 of 1Top StoriesECR 2026When war hits your radiology departmentMore than 2,881 attacks on healthcare in Ukraine have been documented since February 2022. At ECR 2026, a radiologist from Kyiv walked a room of European colleagues through what that actually means for a department, and what to do before it happens to yours.ECR 2026ECR: The scan you've already done: Body composition's missing pictureDigital X-RayStudy finds that AI fails to speed lung cancer diagnosisMolecular ImagingNew FAPI tracer shows promise across 19 solid tumor typesRadiology Education42 countries, 1 standard, and radiology leading the way